Johnson & Johnson (JNJ) Profit After Tax (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Profit After Tax came in at $5.2 billion in Q1 2026, down 52.4% year-on-year from $11.0 billion in Q1 2025, and up 2.33% quarter-over-quarter from $5.1 billion in Q4 2025.

Johnson & Johnson (JNJ) Profit After Tax (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Profit After Tax across 18 years of filings, most recently posting $5.2 billion for Q1 2026.

  • Profit After Tax for Q1 2026 came in at $5.2 billion, down 52.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.0 billion (down 3.53% YoY), and the FY2025 annual result was $26.8 billion, up 90.56% from the prior year.
  • Profit After Tax came in at $5.2 billion for Q1 2026 at Johnson & Johnson, up from $5.1 billion in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $11.0 billion in Q1 2025 to a low of -$491.0 million in Q2 2023.
  • The 5-year median for Profit After Tax is $4.5 billion (2022), against an average of $4.5 billion.
  • Across the five-year window, Profit After Tax slumped 110.74% in 2023 and surged 762.93% in 2024, its largest moves.
  • Johnson & Johnson's Profit After Tax stood at $4.5 billion in 2022, then retreated by 9.17% to $4.0 billion in 2023, then slipped by 15.26% to $3.4 billion in 2024, then jumped by 49.11% to $5.1 billion in 2025, then grew by 2.33% to $5.2 billion in 2026.
  • The last three Profit After Tax figures came in at $5.2 billion (Q1 2026), $5.1 billion (Q4 2025), and $5.2 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 2.48 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 7.40 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 5.24 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 697.00 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -4.24 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 1.82 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 2.02 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 2.71 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 2.68 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 5.24 Bn
Dec 28, 2025 5.12 Bn
Sep 28, 2025 5.15 Bn
Jun 29, 2025 5.54 Bn
Mar 30, 2025 11.00 Bn
Dec 29, 2024 3.43 Bn
Sep 29, 2024 2.69 Bn
Jun 30, 2024 4.69 Bn
Mar 31, 2024 3.26 Bn
Dec 31, 2023 4.05 Bn
Oct 1, 2023 4.31 Bn
Jul 2, 2023 5.38 Bn
Apr 2, 2023 -491.00 Mn
Jan 1, 2023 3.23 Bn
Oct 2, 2022 4.46 Bn
Jul 3, 2022 4.26 Bn
Apr 3, 2022 4.57 Bn
Oct 3, 2021 3.67 Bn
Jul 4, 2021 6.28 Bn
Apr 4, 2021 6.20 Bn